A Gain-of-Function Mutation in TRPA1 Causes familial episodic pain syndrome

ABSTRACT: Human monogenic pain syndromes have provided important insights into the molecular mechanisms that underlie normal and pathological pain states. We describe an autosomal-dominant familial episodic pain syndrome characterized by episodes of debilitating upper body pain, triggered by fasting...

Full description

Autores:
Pineda Trujillo, Nicolás Guillermo
Bedoya Berrío, Gabriel de Jesús
Ruiz Linares, Andrés
Kremeyer, Barbara
Lopera Restrepo, Francisco Javier
Cox, James J.
Momin, Aliakmal
Rugiero, Francois
Marsh, Steve
Woods, C. Geoffrey
Jones, Nicholas G.
Paterson, Kathryn J.
Fricker, Florence R.
Villegas Lanau, Carlos Andrés
Acosta Baena, Natalia
Ramírez, Juan Diego
Zea, Julián
Burley, Mari Wyn
Bennett, David L.H.
Wood, John N.
Tipo de recurso:
Article of investigation
Fecha de publicación:
2010
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/33938
Acceso en línea:
https://hdl.handle.net/10495/33938
Palabra clave:
Análisis de Secuencia de Proteína
Sequence Analysis, Protein
Canales de Calcio
Calcium Channels
Línea Celular
Cell Line
Datos de Secuencia Molecular
Molecular Sequence Data
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/2.5/co/
Description
Summary:ABSTRACT: Human monogenic pain syndromes have provided important insights into the molecular mechanisms that underlie normal and pathological pain states. We describe an autosomal-dominant familial episodic pain syndrome characterized by episodes of debilitating upper body pain, triggered by fasting and physical stress. Linkage and haplotype analysis mapped this phenotype to a 25 cM region on chromosome 8q12–8q13. Candidate gene sequencing identified a point mutation (N855S) in the S4 transmembrane segment of TRPA1, a key sensor for environmental irritants. The mutant channel showed a normal pharmacological profile but altered biophysical properties, with a 5-fold increase in inward current on activation at normal resting potentials. Quantitative sensory testing demonstrated normal baseline sensory thresholds but an enhanced secondary hyperalgesia to punctate stimuli on treatment with mustard oil. TRPA1 antagonists inhibit the mutant channel, promising a useful therapy for this disorder. Our findings provide evidence that variation in the TRPA1 gene can alter pain perception in humans.